GlassScriptPhysician profile
Cassandra Joy Beard
NPI 1508304833
$5,740.19
in general payments reported to CMS, 2019-2025
19 companies · $2,041 in 2025
The $2,041 reported for 2025 was more than what 76% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $36.10 · 2021: $575 · 2022: $961 · 2023: $679 · 2024: $1,010 · 2025: $2,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,336 · Education: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,335.87 |
| Education | $393.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,344.53 | 2025 | M22 |
| Abbvie INC. | $1,025.63 | 2021-2025 | Skyrizi |
| Sun Pharmaceutical Industries INC. | $795.66 | 2021-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $635.78 | 2019-2023 | Dupixent |
| Janssen Biotech, INC. | $573.74 | 2022-2025 | Tremfya, Simponi, Stelara |
| Organogenesis INC. | $401.32 | 2023-2025 | Puraply Wound Matrix, Via Matrix, Puraply |
| Lilly USA, LLC | $177.53 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $119.99 | 2021-2024 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $119.62 | 2023 | Sotyktu |
| Galderma Laboratories, L.P. | $103.23 | 2021-2025 | Nemluvio |
| Almirall LLC | $96.82 | 2022 | |
| Celgene Corporation | $81.06 | 2019 | |
| Genzyme Corporation | $72.21 | 2020-2022 | |
| Ucb, INC. | $70.56 | 2022-2024 | Bimzelx |
| Pfizer INC. | $48.80 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.47 | 2023 | |
| Vyne Pharmaceuticals INC. | $20.13 | 2020 | |
| Allergan, INC. | $19.45 | 2019 | |
| Mayne Pharma Commercial LLC | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Beard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.